Olema Pharmaceuticals, Inc. Insider Transactions
Olema Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Bohen Sean
CEO |
Sell | 52,328 @ $9.37 | $490.31 K | 298,836 | 12/10/2024 | 12/11/2024 | |
|
Harmon Cyrus
Director |
Sell | 8,256 @ $9.37 | $77.36 K | 772,277 | 12/10/2024 | 12/11/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 1,870,499 @ $14.92 | $27.90 M | 4,720,482 | 08/01/2024 | 08/05/2024 | |
|
Paradigm Biocapital Advisors LP
10 percent owner |
Sell | 529,501 @ $14.92 | $7.90 M | 783,118 | 08/01/2024 | 08/05/2024 | |
|
Harmon Cyrus
Director |
Sell | 934 @ $15.55 | $14.52 K | 751,283 | 07/30/2024 | 07/31/2024 | |
|
Harmon Cyrus
Director |
Sell | 4,066 @ $15.58 | $63.35 K | 752,217 | 07/29/2024 | 07/31/2024 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $12.26 | $61.30 K | 756,283 | 07/11/2024 | 07/12/2024 | |
|
Harmon Cyrus
Director |
Sell | 20,000 @ $10.77 | $215.40 K | 761,283 | 06/28/2024 | 07/02/2024 | |
|
Graham G. Walmsley
Director |
Sell | 475,000 @ $14.85 | $7.05 M | 708,114 | 06/04/2024 | 06/06/2024 | |
|
Graham G. Walmsley
Director |
Sell | 700,000 @ $14.85 | $10.40 M | 700,761 | 06/04/2024 | 06/06/2024 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $12.33 | $61.65 K | 781,283 | 06/04/2024 | 06/04/2024 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $10.93 | $54.65 K | 786,283 | 06/03/2024 | 06/04/2024 | |
|
Harmon Cyrus
Director |
Sell | 15,000 @ $9.41 | $141.15 K | 791,283 | 05/31/2024 | 06/04/2024 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $10.92 | $54.60 K | 806,283 | 05/06/2024 | 05/07/2024 | |
|
Harmon Cyrus
Director |
Sell | 15,000 @ $9.51 | $142.65 K | 811,283 | 04/30/2024 | 05/02/2024 | |
|
Harmon Cyrus
Director |
Sell | 20,000 @ $10.97 | $219.40 K | 826,283 | 03/28/2024 | 03/29/2024 | |
|
Harmon Cyrus
Director |
Sell | 24,900 @ $12.41 | $309.01 K | 846,383 | 02/29/2024 | 03/04/2024 | |
|
Harmon Cyrus
Director |
Sell | 100 @ $13.00 | $1.30 K | 846,283 | 02/29/2024 | 03/04/2024 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $15.56 | $77.80 K | 871,283 | 02/01/2024 | 02/02/2024 | |
|
Harmon Cyrus
Director |
Sell | 25,000 @ $12.23 | $305.75 K | 876,283 | 01/31/2024 | 02/02/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. FAQ's
The list of insiders at Olema Pharmaceuticals, Inc. includes Kovacs Shane William Charles, Zojwalla Naseem, Myles David C., Bohen Sean, Harmon Cyrus, Graham G. Walmsley, Bain Capital Life Sciences Investors, LLC.
Insiders have sold a total of 1.64 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 11.60 M sold.
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Kovacs Shane William Charles ($316.70 K), Zojwalla Naseem ($250.46 K), Myles David C. ($234.92 K), Bohen Sean ($986.37 K), Harmon Cyrus ($352.80 K), Graham G. Walmsley ($9.46 M),
Insiders have purchased a total of 300.00 K Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 1.73 M.
The following insiders have purchased Olema Pharmaceuticals, Inc. shares in the last 12 months: Bain Capital Life Sciences Investors, LLC ($1.73 M),